MedPath

Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation

Not Applicable
Recruiting
Conditions
Multiple Myeloma
Lymphoma
Interventions
Other: Best Practice
Procedure: Spiritual Therapy
Registration Number
NCT06328699
Lead Sponsor
Emory University
Brief Summary

This clinical trial tests the feasibility, implementation and acceptability of chaplain delivered compassion meditation in order to improve spiritual care for patients receiving stem cell transplantation. Hospital chaplains play a vital role in delivering emotional and spiritual care to a broad range of both religious and non-religious patients for a wide variety of stressors, and extensive research indicates that spiritual consults impact patient outcomes and satisfaction. Compassion meditation is a secularized, research-based mindfulness and compassion meditation program designed to expand and strengthen compassion for self and others. Practices include training in attentional stability and increased emotional awareness, as well as targeted reflections to appreciate one's relationship with self and others. By centering the mind, controlling debilitating ruminative thoughts, and cultivating personal resiliency and an inclusive and more accurate understanding of others. Engaging in chaplain delivered compassion meditation may improve the spiritual care for patients receiving stem cell transplantation.

Detailed Description

PRIMARY OBJECTIVE:

I. To examine the feasibility, adoption, extent of implementation, acceptability and fidelity of chaplain-delivered compassion-centered spiritual health (CCSH).

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive chaplain-led compassionate centered spiritual health sessions over 30 minutes, twice per week for up to 2 weeks.

ARM II: Patients receive a traditional chaplain consultation and care upon request, per standard of care.

After completion of study treatment, patients are followed up at 80-100 days and 6 months post treatment.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • PATIENT: Within 6 weeks of scheduled hematopoietic stem cell transplant (HSCT)
  • PATIENT: > 18 years of age
  • PATIENT: Speak and read English
  • CHAPLAIN: Emory Healthcare chaplain
Exclusion Criteria
  • PATIENT: Patients will be excluded if they are cognitively impaired, on a ventilator, or are in a room requiring enteric precautions or airborne precautions (e.g., use of an N-95 mask requiring fit-testing) to enter
  • CHAPLAIN: There will be no exclusion criteria and no consequence to the chaplains for refusing to volunteer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm II (Traditional chaplain consultation)Best PracticePatients receive a traditional chaplain consultation and care upon request, per standard of care.
Arm I (Chaplain delivered compassion meditation)Spiritual TherapyPatients receive chaplain led compassionate centered spiritual health sessions over 30 minutes, twice per week for up to 2 weeks.
Primary Outcome Measures
NameTimeMethod
Feasibility - patient enrollment and treatment-specific retention ratesUp to 8 months

Will measure and characterize the proportion of eligible patient screens who enroll and treatment-specific retention rates.

Secondary Outcome Measures
NameTimeMethod
Patient Characteristics Affecting Acceptability - Chaplain Satisfaction SurveyUp to 8 months

We will examine whether scores on the chaplain satisfaction survey vary based on patient sociodemographic variables (biological sex, race)

Functional Assessment of Cancer Therapy-Bone Marrow Transplant [FACT-BMT]Up to 8 months

Impact of chaplain-delivered compassion-centered spiritual health on quality of life

Acceptability - Chaplain Satisfaction SurveyUp to 8 months

Will administer a post- chaplain-based compassion treatment (CBCT) intervention using chaplain satisfaction survey and will ask patients after each session if they would like to continue receiving CBCT sessions.

Trial Locations

Locations (1)

Emory University Hospital/Winship Cancer Institute

🇺🇸

Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute
🇺🇸Atlanta, Georgia, United States
Erin Brauer, MPH
Contact
erin.graf.brauer@emory.edu
© Copyright 2025. All Rights Reserved by MedPath